Normoalbuminuric type 2 diabetes
(n=50)
Micro-albuminuric
type 2 diabetes
(n=50)
Control (n=50) ANOVA Tukey’s test
f p P1 P2 P3
Fasting blood glucse (mg/dl) 214.5 ± 54.7 246.5 ± 65.8 78.1 ± 7.8 121.1 <0.001* 0.003* <0.001* <0.001*
2-h PP blood glucose  (mg/dl) 280.1 ± 63.7 361.3 ± 54.2 95.1 ± 15.9 228.4 <0.001* <0.001* <0.001* <0.001*
HDL (mg/dl) 48.1 ± 8.9 39.6 ± 6.2 48.9 ± 5.1 23.5 <0.001* <0.001* 0.6 <0.001*
TAG (mg/dl) 116.5 ± 42.7 139.9 ± 36.8 96.7 ± 15.1 5.2 0.007 0.02* 0.9 0.01*
TC (mg/dl) 230.4 ± 61.3 271.5 ± 51.6 171.8 ± 32.7 18.8 <0.001* 0.009* 0.01* <0.001*
LDL (mg/dl) 161.1 ± 63.7 204.5 ± 49.3 103.9 ± 28.7 21.1 <0.001* <0.001* 0.26 <0.001*
Fasting insulin (μIU/ml) 8.6 ± 5.6 13.3 ± 4.9 4.1 ± 1.5 21.6 <0.001* <0.001* <0.001* <0.001*
HOMA-IR 4.7 ± 3.8 7.9 ± 4.5 1.1 ± 0.3 23.8 <0.001* 0.001* <0.001* <0.001*
Urinary Albumin/Creatinine ratio (UACR , mg/g) 16.9 ± 9.5 74.6  ± 33.1 18.1 ± 6.3 109.3 <0.001* <0.001* 0.001* <0.001*
Urea (mg %) 33.5 ± 9.1 73.4 ± 18.7 25.7 ± 6.8 135.3 <0.001* <0.001* 0.22 <0.001*
Serum creatinine (mg/dl) 0.79 ± 0.3 0.94 ± 0.7 0.7 ± 0.1 5.5 0.001* <0.001* 0.52 <0.001*
estimated GFR (eGFR ,ml/min per 1.73m2 ) 95.6 ± 29.3 71.5 ± 25.3 94.4 ± 17.3 4.8 0.011* 0.02* 0.98 0.02*
sRAGE, pg/mL 3275 ± 270 4859 ± 317 1562  ± 386 748.7 <0.001* <0.001* <0.001* <0.001*
Pentosidinepg/mL 273 ± 85 298 ±  26 257 ±  43 7.08 0.002* 0.943 0.003* 0.008*
AOPPs (μmol/l) 189 ± 5.1 203.1 ± 7.3 125.83 ± 4.05 1409.7 <0.001* <0.001* <0.001* <0.001*
Data presented as means ± SD. P was calculated by one way ANOVA test followed by Tukey’s post-hoc test. P was considered significant at <0.05.; *Significant; P1 comparison between group I and II; P2 comparison between group I and III; P3 comparison between group II and III.
Table 2: Statistical comparisons between the studied parameters.